In February 2026, a groundbreaking electronic implant system was developed by a collaborative team of scientists from the Perelman School of Medicine at the University of Pennsylvania and the Harvard John A. Paulson School of Engineering and Applied Sciences. This innovative system is designed to monitor and influence the development and maturation of human islet cells through the application of electrical signals. The research team successfully integrated an ultrathin conductive mesh structure into pancreas tissue that was cultured in a laboratory setting. This integration allowed for a seamless connection between the electronic device and the biological tissue, facilitating up to two months of continuous recording of cellular electrical activity and observation of developmental processes. By implementing a 24-hour electrical activity cycle, the islet cells were able to maintain their own rhythm and secrete hormones at optimal times, closely mimicking the function of natural islets. This significant achievement not only provides a crucial technological platform for constructing functionally mature human islets but also opens up new avenues for cell-based diabetes therapies. The findings have been published in the esteemed journal Science.